Intermolecular Chalcogen Bonding between Galectin-3 and an Orally Bioavailable Antagonist

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Synfacts 2024; 20(06): 0654
DOI: 10.1055/s-0043-1774829

Innovative Drug Discovery and Development

Contributor(s):

Antonia F. Stepan (Roche)

,

Nicholas A. Meanwell (Baruch S. Blumberg Institute, U. Michigan, Rutgers U.)

chalcogen bonding - drug–target interactions - carbohydrates - galectin 3 antagonist

Article published online:
14 May 2024

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany